Dopaminergic control of attentional flexibility: Inhibition of return is associated with the dopamine transporter gene (DAT1)

Frontiers in Human Neuroscience

Volumn 4, Issue , 2010, Pages

  Colzato, Lorenza S ^a   Pratt, Jay ^b   Hommel, Bernhard ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dopamine; Dopamine transporter gene; Inhibition of return; Prefrontal cortex; Striatum

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; ARTICLE; ATTENTION; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DNA POLYMORPHISM; DOPAMINERGIC ACTIVITY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INHIBITION OF RETURN; LATENT PERIOD; MALE; MENTAL TASK; NERVE STIMULATION; NORMAL HUMAN; TANDEM REPEAT; TASK PERFORMANCE;

EID: 77956528563     PISSN: 16625161     EISSN: 16625161     Source Type: Journal    
DOI: 10.3389/fnhum.2010.00053     Document Type: Article

References (43)

1. Bertolino, A., Blasi, G., Latorre, V., Rubino, V., Rampino, A., Sinibaldi, L., Caforio, G., Petruzzella, V., Pizzuti, A., Scarabino, T., Nardini, M., Weinberger, D. R., and Dallapiccola, B. (2006). Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J. Neurosci. 26, 3918-3922.
2. Castel, A., Chasteen, A. L., Scialfa, C. T., and Pratt, J. (2003). Adult age differences in the time course of inhibition of return. J. Gerontol.: Psychol. Sci. 58, 256-259.
3. Colzato, L. S., and Hommel, B. (2009). Recreational use of cocaine eliminates inhibition of return. Neuropsychology 23, 125-129.
4. Colzato, L. S., Waszack, F. Nieuwenhuis, S. T., Posthuma, D., and Hommel, B. (2010). The flexible mind is associated with the Catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task switching. Neuropsychologia. doi: 10.1016/j. neuropsychologia.2010.04.023.
5. Cools, R. (2008). Role of dopamine in the motivational and cognitive control of behaviour. Neuroscientist 14, 381-395.
6. Cools, R., and D'Esposito, M. (2009). "Dopaminergic modulation of flexible cognitive control in humans," in Dopamine Handbook. eds A. Björklund, S. Dunnett, L. Iversen, and S. Iversen (Oxford: Oxford University Press), pp 249-260.
7. Couette, M., Bachoud-Levi, A. C., Brugieres, P., Sieroff, E., and Bartolomeo, P. (2008). Orienting of spatial attention in Huntington's disease. Neuropsychologia 46, 1391-400.
8. Dickinson, S. D., Sabeti, J., Larson, G. A., Giardina, K., Rubinstein, M., Kelly, M. A., Grandy, D. K., Low, M. J., Gerhardt, G. A., and Zahniser, N. R. (1999). Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72, 148-156.
9. DNA Genotek, Inc. (2006). Oragene TM Product Brochure. Ottawa: DNA Genotek, Inc
10. Dorris, M. C., Klein, R. M., Everling, S., and Munoz, D. P. (2002). Contribution of the primate superior colliculus to inhibition of return. J. Cogn. Neurosci. 14, 1256-1263.
11. Elzinga, B. M., Ardon, A. M., Heijnis, M. K., de Ruiter, M. B., van Dyck, R., and Veltman, D. J. (2007). Neural correlates of enhanced working-memory performance in dissociative disorder: a functional MRI study. Psychol. Med. 37, 235-245.
12. Elzinga, B. M., Roelofs, K., Tollenaar, M. S., Bakvis, P., van Pelt, J., and Spinhoven, P. (2008). Diminished cortisol responses to psychosocial stress associated with lifetime adverse events: a study among healthy young subjects. Psychoneuroendocrinology 33, 227-237.
13. Fecteau, J. H., and Munoz, D. P. (2005). Correlates of raphne of attention and inhibition of return across stages of visual processing. J. Cogn. Neurosci. 17, 1714-1727.
14. Fecteau, J. H., and Munoz, D. P. (2003). Exploring the consequences of the previous trial. Nat. Rev. Neurosci. 4, 435-443.
15. Fillmore, M. T., Rush, C. R., and Abroms, B. D. (2005). d-Amphetamineinducedenhancement of inhibitory mechanisms involved in visual search. Exp. Clin. Psychopharmacol. 13, 200-208.
16. Filoteo, J. V., Delis, D. C., Salmon, D. P., Demadura, T., Roman, M. J., and Shults, C. W. (1997). An examination of the nature of attentional deficits in patients with Parkinson's disease: evidence from a spatial orienting task. J. Int. Neuropsychol. Soc. 3, 337-347.
17. Giros, B., Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., Caron, M. G. (1992). Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383-390.
18. Goschke, T. (2000). "Involuntary persistence and intentional reconfiguration in task-set switching," in Attention and performance XVIII: control of Cognitive Processes, eds S. Monsell and J. Driver (Cambridge, MA: MIT Press), 331-355.
19. Hikosaka, O., and Wurtz, R. H. (1985a). Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus. J. Neurophysiol. 53, 266-291.
20. Hikosaka, O., and Wurtz, R. H. (1985b). Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in the monkey substantia nigra. J. Neurophysiol. 53, 292-308.
21. Kang, A. M., Palmatier, M. A., and Kidd, K. K. (1999). Global variation of a 40-bp VNTR in the 30-untranslated region of the dopamine transporter gene (SLC6A3). Biol. Psychiatry 46, 151-160.
22. Karoum, F., Chrapusta, S. J., and Egan, M. F. (1994). 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J. Neurochem. 63, 972-979.
23. Klein, R. M. (1988). Inhibitory tagging system facilitates visual search. Nature 334, 430-431.
24. Langley, L. K., Fuentes, L. J., Vivas, A. B., and Saville, A. L. (2007). Aging and temporal patterns of inhibition of return. J. Gerontol. B: Psychol. Sci. Soc. Sci. 62, 71-77.
25. Lecrubier, Y., Sheehan, D. V., Weiller, E., Amorim, P., Bonara, I., Sheehan, K., Janavs, J., Dunbar, G. (1997). The mini international neuropsychiatric interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry 12, 224-231.
26. Logan, G. D. (1994). "On the ability to inhibit thought and action: a users' guide to the stop signal paradigm," in Inhibitory Processes in Attention, Memory and Language, eds D. Dagenbach and T. H. Carr (San Diego: Academic Press), 189-239.
27. Lupianez, J., Decaix, C., Sieroff, B., Milliken, B., and Bartolomeo, P. (2004). Independent effects of endogenous and exogenous spatial cueing: Inhibition of return for endogenously attended target locations. Exp. Brain Res. 159, 447-457.
28. Lupianez, J., Milliken, B., Solano, C., Weaver, B., and Tipper, S. P. (2001). On the strategic modulation of the time course of facilitation and inhibition of return. Q. J. Exp. Psychol. 54A, 753-773.
29. Meiergerd, S. M., Patterson, T. A., and Schenk, J. O. (1993). D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764-767.
30. Mitchell, R. J., Howlett, S., Earl, L., White, N. G., Crawford, M. H., McComb, J., Schanfield, M. S., Briceno, I., Papiha, S. S., Osipova, L., Livshits, G., Leonard, W. R., and Crawford, M. H. (2000). The distribution of the 3'VNTR polymorphism in the human dopamine transporter gene in world populations. Hum. Biol. 72, 295-304.
31. Mortensen, O. V., and Amara, S. G. (2003). Dynamic regulation of the dopamine transporter. Eur. J. Pharmacol. 479, 159-170.
32. Poliakoff, E., O'Boyle, D. J., Moore, A. P., McGlone, F. P., Cody, F. W. J., and Spence, C. (2003). Orienting of attention and Parkinson's disease: tactile inhibition of return and response inhibition. Brain 126, 2081-2092.
33. Posner, M. I., and Cohen, Y. (1984). "Components of visual orienting," in Attention and Performance X: Control of Language Processes, eds H. Bouma and D. G. Bouwhuis (Hillsdale, NJ: Erlbaum), 531-556.
34. Raven, J. C., Court, J. H., and Raven, J. (1988). Manual for Raven's progressive matrices and vocabulary scales. London: Lewis.
35. Ro, T., Farné, A., and Chang, E. (2003). Inhibition of return and the human frontal eye fields. Exp. Brain Res. 150, 290-296.
36. Schiller, P. H., and Tehovnik, E. J. (2005). Neural mechanisms underlying target selection with saccadic eye movements. Prog. Brain Res. 149, 157-171.
37. Seamans, J. K., Yang, C. R. (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74, 1-58.
38. Sesack, S. R., Hawrylak, V. A., Matus, C., Guido, M. A., and Levey, A. I. (1998). Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18, 2697-2708.
39. Sheehan, D. V., Lecrubier, Y., Sheenan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., and Dunbar, G. C. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59, 22-23.
40. Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W. et al. (1992). Human dopamine transporter gene maps to chromosome 5p15.3 and displays a VNTR. Genomics 14, 1104-1106.
41. Volkow, N. D., Fowler, J. S., and Wang, G. J. (1999). Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J. Psychopharmacol. 13, 337-345.
42. Waldman, I. D., Rowe, D. C., Abrinteamowitz, S., Kozel, T., Mohr, J. H., Sherman, L. et al. (1998). Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63, 1767-1776.
43. Yamaguchi, S., and Kobayashi, S. (1998). Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention. J. Neurosci. 18, 1869-1878.